Publication:
Bronchodilatation Effects of Dry Powder Formoterol Fumarate in Asthmatic Patients

dc.contributor.authorSawang Saenghirunvattanaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-04T07:47:31Z
dc.date.available2018-07-04T07:47:31Z
dc.date.issued1997-10-01en_US
dc.description.abstractTen asthmatic patients were enrolled in our study of the effects of dry powder formoterol fumarate. The onest was 2-5 minutes and a long duration of action (over 12 hours) appeared. The mean baseline FEV1 was 1.67 liters (49-74%). Mean reversibility was 17 per cent (range 15-19%). There was no adverse effect in this study.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.80, No.10 (1997), 657-661en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-2442655762en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/18069
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=2442655762&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleBronchodilatation Effects of Dry Powder Formoterol Fumarate in Asthmatic Patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=2442655762&origin=inwarden_US

Files

Collections